Indoco Remedies Share Price
Indoco Remedies Share Price Today
As of 5 Jul 2026, Indoco Remedies share price is ₹244.90. The stock opened at ₹243.70, compared to its previous close of ₹244.02. During today's trading session, Indoco Remedies share price moved in the range of ₹242.10 to ₹251.50, with an average price of ₹246.80 for the day. Looking at its last 52-week, the stock has touched a low of ₹162.19 and a high of ₹349.80. On the performance front, Indoco Remedies share price has increased by 7.65% over the last six months and is down 27.98% on a year-on-year basis.
Indoco Remedies Returns Calculator
Indoco Remedies Shareholder Returns
Indoco Remedies Share Price History
| Name | Mkt Cap Cr | P/E | P/B | ROE | D/E | ROCE | Book Value | Div. Yield | Turnover | EPS(TTM) |
|---|---|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 4,49,048.00 | 39.02 | 5.37 | 13.74% | 0.61 | 17.33% | 93.24 | 0.85% | 0.56 | 10.90 |
| Divis Laboratories | 1,77,179.00 | 69.00 | 10.57 | 15.32% | 0.00 | 19.56% | 629.49 | 0.45% | 0.58 | 98.19 |
| Torrent Pharmaceuticals | 1,57,804.00 | 66.03 | 17.03 | 26.76% | 1.05 | 18.30% | 16.90 | 0.90% | 0.49 | 64.75 |
| Cipla | 1,17,642.00 | 25.47 | 2.87 | 11.79% | 0.00 | 15.66% | 2.89 | 1.06% | 0.49 | 43.52 |
| Dr. Reddy's Laboratories | 1,12,368.00 | 27.03 | 2.97 | 11.07% | 0.18 | 12.54% | 375.78 | 0.59% | 0.63 | 38.68 |
| Zydus Lifesciences | 1,10,651.00 | 21.60 | 4.08 | 18.59% | 0.31 | 17.35% | 235.25 | 0.09% | 0.39 | 35.38 |
| Lupin | 1,09,676.00 | 20.48 | 4.89 | 23.76% | 0.04 | 24.88% | 659.05 | 0.75% | 0.61 | 129.18 |
| Mankind Pharma | 1,02,729.00 | 53.00 | 6.30 | 11.74% | 0.34 | 13.13% | 397.02 | 0.04% | 0.54 | 49.37 |
| Aurobindo Pharma | 90,608.00 | 25.87 | 2.39 | 9.25% | 0.19 | 11.76% | 391.14 | 0.26% | 0.48 | 41.58 |
| Laurus Labs | 82,398.90 | 60.26 | 10.10 | 18.21% | 0.45 | 16.70% | 10.19 | 0.20% | 0.97 | 13.72 |
Indoco Remedies Financials
Income Statement · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,664.92 | ₹1,817.29 | ₹1,668.61 | ₹1,540.75 |
| Other Income | ₹5.45 | ₹9.85 | ₹2.34 | ₹2.33 |
| Total Revenue | ₹1,670.37 | ₹1,827.13 | ₹1,670.95 | ₹1,543.08 |
| Total Expenses | ₹1,745.74 | ₹1,702.86 | ₹1,478.15 | ₹1,306.51 |
| Profit Before Tax | -₹74.37 | ₹135.80 | ₹192.79 | ₹236.57 |
| Tax | ₹3.58 | ₹38.79 | ₹50.54 | ₹81.77 |
| Profit After Tax | -₹77.95 | ₹97.00 | ₹142.25 | ₹154.80 |
| EPS - Basic | -₹8.46 | ₹10.53 | ₹15.44 | ₹16.80 |
| EPS - Diluted | -₹8.45 | ₹10.51 | ₹15.42 | ₹16.80 |
Cash Flow · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹75.36 | ₹124.27 | ₹192.79 | ₹236.57 |
| Income before WC changes | ₹108.27 | ₹261.82 | ₹313.67 | ₹323.69 |
| Change in Assets | -₹48.16 | -₹145.24 | -₹61.45 | -₹142.37 |
| Change in Liabilities | ₹50.94 | ₹58.07 | -₹11.74 | ₹33.59 |
| Change in WC | ₹2.78 | -₹87.16 | -₹73.19 | -₹108.79 |
| Cash flow from Operations | ₹94.93 | ₹156.70 | ₹178.83 | ₹173.83 |
| Cash flow from Investing | -₹339.11 | -₹433.83 | -₹208.17 | -₹121.41 |
| Cash flow from Financing | ₹241.42 | ₹280.43 | ₹22.80 | -₹44.37 |
| Total Cash Flow | -₹2.76 | ₹3.31 | -₹6.54 | ₹8.05 |
| Cash (Start of the year) | ₹14.86 | ₹10.92 | ₹17.47 | ₹9.42 |
| Cash (End of the year) | ₹12.10 | ₹14.86 | ₹10.92 | ₹17.47 |
Balance Sheet · Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,428.58 | ₹1,190.06 | ₹844.63 | ₹712.47 |
| Current Assets | ₹1,001.34 | ₹954.67 | ₹813.57 | ₹773.62 |
| Total Assets | ₹2,429.91 | ₹2,144.73 | ₹1,658.20 | ₹1,486.09 |
| Current Liabilities | ₹807.99 | ₹612.33 | ₹424.51 | ₹424.85 |
| Net Current Asset | ₹193.34 | ₹342.34 | ₹389.06 | ₹348.77 |
| Non-Current Liabilities | ₹603.54 | ₹421.90 | ₹205.44 | ₹156.60 |
| Equity Capital | ₹1,018.38 | ₹1,110.50 | ₹1,028.25 | ₹904.64 |
| Total Equity & Liabilities | ₹2,429.91 | ₹2,144.73 | ₹1,658.20 | ₹1,486.09 |
Income Statement · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Revenue | ₹1,518.19 | ₹1,790.81 | ₹1,666.69 | ₹1,539.72 |
| Other Income | ₹18.48 | ₹8.51 | ₹2.33 | ₹2.32 |
| Total Revenue | ₹1,536.67 | ₹1,799.32 | ₹1,669.02 | ₹1,542.04 |
| Total Expenses | ₹1,545.04 | ₹1,657.62 | ₹1,477.43 | ₹1,305.81 |
| Profit Before Tax | -₹7.38 | ₹153.23 | ₹191.59 | ₹236.23 |
| Tax | ₹1.36 | ₹36.58 | ₹50.23 | ₹81.71 |
| Profit After Tax | -₹8.74 | ₹116.64 | ₹141.36 | ₹154.52 |
| EPS - Basic | -₹0.95 | ₹12.66 | ₹15.34 | ₹16.77 |
| EPS - Diluted | -₹0.95 | ₹12.64 | ₹15.32 | ₹16.77 |
Cash Flow · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Profit before tax | -₹8.37 | ₹141.70 | ₹191.59 | ₹236.23 |
| Income before WC changes | ₹138.85 | ₹271.78 | ₹312.47 | ₹323.35 |
| Change in Assets | -₹53.54 | -₹95.81 | -₹61.47 | -₹142.58 |
| Change in Liabilities | ₹21.05 | ₹18.39 | -₹10.82 | ₹33.77 |
| Change in WC | -₹32.49 | -₹77.42 | -₹72.29 | -₹108.81 |
| Cash flow from Operations | ₹90.77 | ₹176.78 | ₹178.79 | ₹173.55 |
| Cash flow from Investing | -₹259.79 | -₹301.70 | -₹208.51 | -₹121.41 |
| Cash flow from Financing | ₹168.62 | ₹122.40 | ₹22.81 | -₹44.37 |
| Total Cash Flow | -₹0.41 | -₹2.52 | -₹6.91 | ₹7.77 |
| Cash (Start of the year) | ₹7.47 | ₹9.99 | ₹16.90 | ₹9.13 |
| Cash (End of the year) | ₹7.06 | ₹7.47 | ₹9.99 | ₹16.90 |
Balance Sheet · Standalone
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|
| Non-Current Assets | ₹1,245.69 | ₹1,060.39 | ₹847.21 | ₹714.79 |
| Current Assets | ₹955.47 | ₹900.21 | ₹812.47 | ₹772.78 |
| Total Assets | ₹2,201.16 | ₹1,960.61 | ₹1,659.67 | ₹1,487.57 |
| Current Liabilities | ₹695.01 | ₹562.25 | ₹427.24 | ₹426.70 |
| Net Current Asset | ₹260.46 | ₹337.96 | ₹385.23 | ₹346.08 |
| Non-Current Liabilities | ₹402.79 | ₹271.74 | ₹205.41 | ₹156.57 |
| Equity Capital | ₹1,103.36 | ₹1,126.62 | ₹1,027.02 | ₹904.30 |
| Total Equity & Liabilities | ₹2,201.16 | ₹1,960.61 | ₹1,659.67 | ₹1,487.57 |
About Indoco Remedies
Indoco Remedies Limited is an India-based fully integrated, research-oriented pharmaceutical company. The Company is engaged in the manufacturing and marketing of formulations (finished dosage forms) and active pharmaceutical ingredients (APIs). The Company caters to both Domestic and International markets. Its products include SENSODENT-K, HOMIDE, DEXOREN-S, LORCHEK-MR, SENSOFORM, KIDODENT, NINAF, KARVOL PLUS, CYCLOPAM, LIGNOX+ADRENLINE, NOXA, CITAL-UTI, RENOLEN, REXIDIN-M, CITAL, SENSODENT-KF, CARMICIDE, TOBAREN-DM, FEBREX PLUS, SCABEX, CLOBEN-G, MOFLOREN-BF, OTOREX, ZINCOREN, SENOLIN, LIGNOX, HEMSYL, FEDRIS, REXIDIN, VEPAN, OXIPOD, TURBOCORT, MACUCHEK, and DENTOGEL. The Company has around 11 manufacturing facilities, seven for finished dosage forms (FDFs) and four for active pharmaceutical ingredients (APIs), supported by a research and development center and a clinical research organization facility.
Indoco Remedies Financial Highlights
- Revenue: Indoco Remedies reported revenue of ₹1,848.65 crore in FY26 vs ₹1,670.37 crore in FY25. It showed an increase of 10.67% on a yearly basis.
- Operating Profit: Indoco Remedies reported an operating loss of ₹106.51 crore in FY26 vs ₹74.37 crore in FY25. It showed a decrease of 43.22% on a year-on-year basis.
- Net Profit: Indoco Remedies reported a net loss of ₹98.70 crore in FY26 vs ₹77.95 crore in FY25. It showed a decrease of 26.62% on a yearly basis.
Indoco Remedies Quarterly Result Highlights
- Indoco Remedies reported revenue of ₹475.57 crore in Mar 2026, compared with ₹446.34 crore in Dec 2025, representing an increase of 6.55% on a quarter-on-quarter (QoQ) basis.
- Indoco Remedies reported an operating loss of ₹25.00 crore in Mar 2026, compared with ₹31.31 crore in Dec 2025, representing an increase of 20.15% on a quarter-on-quarter (QoQ) basis.
- Indoco Remedies reported a loss of ₹23.68 crore in Mar 2026, compared with ₹29.45 crore in Dec 2025, reflecting an increase of 19.59% on a QoQ basis.
- The earnings per share (EPS) of Indoco Remedies stood at ₹8.46 during Mar 2026.
Similar Stocks
FAQs on Indoco Remedies Share Price
What is Indoco Remedies share price today?
Indoco Remedies share price is ₹244.90 as on 03 Jul, 2026, 15:29 IST.
How has the Indoco Remedies share price performed in the past?
In the last 1 year, Indoco Remedies delivered a return of -27.98%. The Indoco Remedies share price hit a high of ₹349.80 and low of ₹162.19.
How much is the Mutual Fund shareholding in Indoco Remedies shares?
The Mutual Fund Shareholding in Indoco Remedies was 17.54% at the end of Mar 2026.
What is the the 52-week high and low of Indoco Remedies shares ?
The 52-week high and low of Indoco Remedies share is ₹349.80 and ₹162.19 as of 03 Jul, 2026.
What is the market cap of Indoco Remedies?
The market capitalisation of Indoco Remedies is ₹2,246.21 Crores as on 03 Jul, 2026.
What are the stock symbols of Indoco Remedies?
The stock symbol of Indoco Remedies is INDOCO on the NSE, 532612 on the BSE, and the ISIN is INE873D01024.
What was yesterday's closing price of Indoco Remedies shares ?
Indoco Remedies shares closed yesterday at ₹244.02 on NSE & ₹243.35 on BSE
How to buy Indoco Remedies shares?
To buy Indoco Remedies shares, open a demat account with Upstox and complete the KYC process. Once your account is set up, search for the stock and place your order.
Can I buy Indoco Remedies shares on Holidays?
No, shares of Indoco Remedies or any other publicly traded company cannot be bought or sold on holidays when the stock exchanges are closed. You can only buy or sell Indoco Remedies shares on days when the stock exchanges are open for trading. It's important to check the NSE & BSE holidays calendar, before placing any trades to avoid any inconvenience.
What is the PE and PB ratio of Indoco Remedies?
The PE and PB ratio of Indoco Remedies is -22.76 and 2.39 respectively, as on 03 Jul, 2026, 15:29 IST.